Mr. Holden speaks to issues including the company’s top volume procedures, trends driving future growth, impact of removal of the copay for screening rates for colonoscopies and the company’s approach to acquisitions.
Read the Q&A from The Tennessean with Christopher Holden.
Read more about AmSurg:
– AmSurg Reports 11% Increase in Revenues, 2% Increase in Average Revenue Per Procedure
